- Home
- VSTM
VSTM
Verastem Inc.
as of 12-17-2025 3:55pm EST
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | NEEDHAM |
| Market Cap: | 723.8M | IPO Year: | 2012 |
| Target Price: | $13.38 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.98 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.46 - $11.24 | Next Earning Date: | 11-04-2025 |
| Revenue: | $13,379,000 | Revenue Growth: | 33.79% |
| Revenue Growth (this year): | 183.1% | Revenue Growth (next year): | 271.39% |
Stock Insider Trading Activity of Verastem Inc. (VSTM)
President and CEO
Avg Cost/Share
$10.25
Shares
2,000
Total Value
$20,500.00
Owned After
414,818
SEC Form 4
President and CEO
Avg Cost/Share
$10.50
Shares
2,000
Total Value
$21,000.00
Owned After
414,818
SEC Form 4
President and CEO
Avg Cost/Share
$10.61
Shares
2,000
Total Value
$21,220.00
Owned After
414,818
SEC Form 4
President and CEO
Avg Cost/Share
$10.00
Shares
2,000
Total Value
$20,000.00
Owned After
414,818
SEC Form 4
President and CEO
Avg Cost/Share
$10.00
Shares
2,000
Total Value
$20,000.00
Owned After
414,818
SEC Form 4
President and CEO
Avg Cost/Share
$10.32
Shares
2,000
Total Value
$20,640.00
Owned After
414,818
SEC Form 4
President and CEO
Avg Cost/Share
$10.39
Shares
2,000
Total Value
$20,780.00
Owned After
414,818
SEC Form 4
President and CEO
Avg Cost/Share
$10.79
Shares
2,000
Total Value
$21,580.00
Owned After
414,818
SEC Form 4
President and CEO
Avg Cost/Share
$10.32
Shares
2,000
Total Value
$20,640.00
Owned After
414,818
SEC Form 4
President and CEO
Avg Cost/Share
$10.00
Shares
2,000
Total Value
$20,000.00
Owned After
414,818
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Paterson Dan | VSTM | President and CEO | Dec 9, 2025 | Sell | $10.25 | 2,000 | $20,500.00 | 414,818 | |
| Paterson Dan | VSTM | President and CEO | Dec 8, 2025 | Sell | $10.50 | 2,000 | $21,000.00 | 414,818 | |
| Paterson Dan | VSTM | President and CEO | Dec 5, 2025 | Sell | $10.61 | 2,000 | $21,220.00 | 414,818 | |
| Paterson Dan | VSTM | President and CEO | Dec 4, 2025 | Sell | $10.00 | 2,000 | $20,000.00 | 414,818 | |
| Paterson Dan | VSTM | President and CEO | Dec 3, 2025 | Sell | $10.00 | 2,000 | $20,000.00 | 414,818 | |
| Paterson Dan | VSTM | President and CEO | Dec 2, 2025 | Sell | $10.32 | 2,000 | $20,640.00 | 414,818 | |
| Paterson Dan | VSTM | President and CEO | Dec 1, 2025 | Sell | $10.39 | 2,000 | $20,780.00 | 414,818 | |
| Paterson Dan | VSTM | President and CEO | Nov 28, 2025 | Sell | $10.79 | 2,000 | $21,580.00 | 414,818 | |
| Paterson Dan | VSTM | President and CEO | Nov 26, 2025 | Sell | $10.32 | 2,000 | $20,640.00 | 414,818 | |
| Paterson Dan | VSTM | President and CEO | Nov 25, 2025 | Sell | $10.00 | 2,000 | $20,000.00 | 414,818 |
Compare VSTM vs Leading Stocks
See how VSTM stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "VSTM Verastem Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.